Skip to main content
. 2021 Feb 22;11:554922. doi: 10.3389/fendo.2020.554922

Figure 6.

Figure 6

Knockdown of FGF19 did not alter downregulation of CYP7A1 mRNA expression by chenodeoxycholic acid (CDCA). Primary human hepatocytes were treated with siRNA targeting FGF19 or non-targeting control. (A) FGF19 mRNA expression, (B) protein levels in medium in control cultures, after induction by 10 µM CDCA. (C) CYP7A1 mRNA expression, (D) cholic acid (CA) concentration in cell medium. Data is presented as median with interquartile range (IQR). Friedman test was used to assess differences between control and treatments and Dunn’s multiple comparison test was used post-hoc. Each colored dot represents one individual case (n = 3). *p < 0.05.